How Strong Is ProPhase Labs' Balance Sheet? According to the last reported balance sheet, ProPhase Labs had liabilities of US$16.7m due within 12 months, and liabilities of US$13.1m due beyond 12 ...
ProPhase Labs, Inc. announced that CEO Ted Karkus will present at the upcoming Investor Summit Virtual on March 11, 2025, at 1:30 P.M. ET, offering investors insights into the company's operations and ...
ProPhase Labs is a diversified biotech company with profitable existing product lines and plans for expansion. The company's subsidiary, Nebula Genomics, offers whole genome sequencing and plans to ...
UNIONDALE, NY, Feb. 02, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”) is pleased to invite investors to a webinar on Tuesday, February 3, 2026, at 4:15 p.m. ET ...
Each Initiative Has the Potential to Drive Significant Liquidity and Strengthen the Company’s Balance Sheet. UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc.
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We have processed the filings of the more than ...
ProPhase Labs (PRPH) explores sale/partnership for BE-Smart esophageal cancer test and updates Crown Medical COVID claim recoveries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results